Bin Wang

Person

Brighton, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 12,018,017
- Issue date Jun 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,834,436
- Issue date Dec 5, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,560,368
- Issue date Jan 24, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 11,555,032
- Issue date Jan 17, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 11,345,699
- Issue date May 31, 2022
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 11,034,684
- Issue date Jun 15, 2021
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 11,008,304
- Issue date May 18, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,988,458
- Issue date Apr 27, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparation of sulfonylurea bile acid derivatives
- Patent number 10,947,264
- Issue date Mar 16, 2021
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,689,391
- Issue date Jun 23, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,683,279
- Issue date Jun 16, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...
- Patent number 10,597,382
- Issue date Mar 24, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Urea-containing isoxazole derivatives as FXR agonists and methods o...
- Patent number 10,597,391
- Issue date Mar 24, 2020
- Enanta Pharmaceuticals, Inc.
- Jing He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparation of sulfonylurea bile acid derivatives
- Patent number 10,584,145
- Issue date Mar 10, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,450,301
- Issue date Oct 22, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,450,306
- Issue date Oct 22, 2019
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,253,018
- Issue date Apr 9, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Apoptosis signal-regulating kinase 1 inhibitors and methods of use...
- Patent number 10,246,439
- Issue date Apr 2, 2019
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,149,835
- Issue date Dec 11, 2018
- Elmore Patent Law Group, P.C.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole analogs as FXR agonists and methods of use thereof
- Patent number 10,144,729
- Issue date Dec 4, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use therof
- Patent number 10,138,228
- Issue date Nov 27, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,741
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,743
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole derivatives as FXR agonists and methods of use thereof
- Patent number 10,080,742
- Issue date Sep 25, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole derivatives
- Patent number 9,765,087
- Issue date Sep 19, 2017
- Enanta Pharmaceuticals, Inc.
- Yao-Ling Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Deuterated nucleoside/tide derivatives
- Patent number 9,718,851
- Issue date Aug 1, 2017
- Enanta Pharmaceuticals, Inc.
- Jay R. Luly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic proline derived HCV serine protease inhibitors
- Patent number 9,220,748
- Issue date Dec 29, 2015
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic proline derived HCV serine protease inhibitors
- Patent number 8,648,037
- Issue date Feb 11, 2014
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20240376079
- Publication date Nov 14, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused Heterobicyclic Antiviral Agents
- Publication number 20240368096
- Publication date Nov 7, 2024
- Enanta Pharmaceuticals, Inc.
- Samuel BARTLETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Covalent Inhibitors As Antiviral Agents
- Publication number 20240327334
- Publication date Oct 3, 2024
- Enanta Pharmaceuticals, Inc.
- Xuri GAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240228464
- Publication date Jul 11, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS
- Publication number 20240207224
- Publication date Jun 27, 2024
- Enanta Pharmaceuticals, Inc.
- Jiajun Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED HETEROBICYCLIC ANTIVIRAL AGENTS
- Publication number 20240140922
- Publication date May 2, 2024
- Enanta Pharmaceuticals, Inc.
- Samuel Bartlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20240132476
- Publication date Apr 25, 2024
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...
- Publication number 20230416268
- Publication date Dec 28, 2023
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20230174515
- Publication date Jun 8, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...
- Publication number 20230143250
- Publication date May 11, 2023
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20220356167
- Publication date Nov 10, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20220119366
- Publication date Apr 21, 2022
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200361920
- Publication date Nov 19, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200331890
- Publication date Oct 22, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20200270303
- Publication date Aug 27, 2020
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES
- Publication number 20200247839
- Publication date Aug 6, 2020
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20200157095
- Publication date May 21, 2020
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20200079764
- Publication date Mar 12, 2020
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190337923
- Publication date Nov 7, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20190263860
- Publication date Aug 29, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20190194216
- Publication date Jun 27, 2019
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...
- Publication number 20190062310
- Publication date Feb 28, 2019
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...
- Publication number 20180362501
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362502
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180362503
- Publication date Dec 20, 2018
- Enanta Pharmaceuticals, Inc.
- Brett Granger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...
- Publication number 20180327388
- Publication date Nov 15, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS
- Publication number 20180162905
- Publication date Jun 14, 2018
- Enanta Pharmaceuticals, Inc.
- Yat Sun Or
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES
- Publication number 20180148469
- Publication date May 31, 2018
- Enanta Pharmaceuticals, Inc.
- Guoqiang Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS O...
- Publication number 20180141941
- Publication date May 24, 2018
- Enanta Pharmaceuticals, Inc.
- Jing He
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20180099957
- Publication date Apr 12, 2018
- Enanta Pharmaceuticals, Inc.
- Jun Ma
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole analogs as FXR agonists and methods of use thereof

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Process for preparation of sulfonylurea bile acid derivatives

Isoxazole analogs as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitor...

Urea-containing isoxazole derivatives as FXR agonists and methods o...

Process for preparation of sulfonylurea bile acid derivatives

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole analogs as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Apoptosis signal-regulating kinase 1 inhibitors and methods of use...

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use therof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Isoxazole derivatives as FXR agonists and methods of use thereof

Benzimidazole derivatives

Deuterated nucleoside/tide derivatives

Macrocyclic proline derived HCV serine protease inhibitors

Macrocyclic proline derived HCV serine protease inhibitors

Patents Applicationslast 30 patents

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

Fused Heterobicyclic Antiviral Agents

Covalent Inhibitors As Antiviral Agents

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC CHALCONE-AMIDE DERIVED ANTIVIRAL AGENTS

FUSED HETEROBICYCLIC ANTIVIRAL AGENTS

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

PYRIMIDINONE-CONTAINING 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 13 INHIBITORS AND METHODS...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS OF USE THEREOF

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF

TETRAZOLE CONTAINING APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITOR...

Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE...

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

PROCESS FOR PREPARATION OF SULFONYLUREA BILE ACID DERIVATIVES

UREA-CONTAINING ISOXAZOLE DERIVATIVES AS FXR AGONISTS AND METHODS O...

ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF